Protests against Abbott laboratory in Bangkok

Donate patents

A bad example from the US

A public sector technology transfer bill focuses exclusively on patenting

Patents Vs Patients

WTO's conundrum: cheap drugs for poor countries or protecting North's business interests

The irrelevance of multilateralism

Rich countries gang up for a more strident intellectual property rights regime

Indian company gets licence to manufacture and sell patented cancer drug

This is the first-ever compulsory licence given to a generic drug company

In short

Cut-and-paste patent report withdrawn

India rejects Microsoft's Office Open XML

A treaty to block cheaper drugs

Developed countries to use a geographical advantage to stop generics

Gene patent verdict is as good as it gets

The US Supreme Court’s verdict in the Myriad case keeps everyone happy

Back where it belongs

India emerges victorious from a legal wrangle with the US over the patenting of neem

Traditional Indian medicinal practices now safe

Chirala saree weavers losing out to computer-aided designs

The scent that sells

US piles on the pressure

Patent law, domestic content rules in solar and ICT policy come under attack

In Court

In Short

Fight over Novartis's patent to intensify

Sri Lanka bans export of high-value medicinal plant

Madras HC dismisses Novartis' petition

Ranbaxy fights Pfizer on generic drugs but wants strong home law on patents

Nagaur breaks free of pharma stranglehold

Rajasthan, Tamil Nadu make quality drugs affordable

No patent linkage

Bayer’s attempt to pre-empt Cipla’s cancer drug fails

Indications of a geographic muddle

Are Geographical Indications safeguarding the interests of growers and artisans?